Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification
ZHANG Li, LIU Xiao-Ming, GUO Ye, YANG Wen-Yu, ZHANG Jia-Yuan, LIU Fang, LIU Tian-Feng, WANG Shu-Chun, CHEN Xiao-Juan, RUAN Min, QI Ben-Quan, CHANG Li-Xian, ZOU Yao, CHEN Yu-Mei, ZHU Xiao-Fan
Department of Pediatrics, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China
Abstract Objective To investigate the application of multiplex ligation-dependent probe amplification (MLPA) in the detection of copy number variations (CNVs) in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia (ALL), to compare this method with conventional karyotype analysis and fluorescence in situ hybridization (FISH), and to evaluate the value of MLPA. Methods The clinical data of 95 children with ETV6/RUNX1-positive ALL who were treated from January 2006 to November 2012 were analyzed retrospectively, including clinical features, results of karyotype analysis, and results of FISH. CNVs were detected with MLPA. Results CNVs were detected in 73 (77%) , and the median number of CNVs was 1 (range 0-6). The CNVs of EBF1, CDKN2A/2B, PAX5, ETV6, RB1, and BTG1 were detected in more than 10% of all the patients. The changes in the chromosome segments carrying the genes with CNVs detected by MLPA were not detected by conventional karyotype analysis. The coincidence rate between the CNVs in ETV6 gene detected by FISH and those detected by MLPA was 66%. Conclusions MLPA is an efficient and convenient method to detect CNVs in children with ETV6/RUNX1-positive ALL.
ZHANG Li,LIU Xiao-Ming,GUO Ye et al. Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification[J]. CJCP, 2016, 18(1): 34-38.
ZHANG Li,LIU Xiao-Ming,GUO Ye et al. Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification[J]. CJCP, 2016, 18(1): 34-38.
Lilljebjörn H, Heidenblad M, Nilsson B, et al. Combined highresolution array-based comparative genomic hybridization and expression profiling of ETV6/RUNX1-positive acute lymphoblastic leukemias reveal a high incidence of cryptic Xq duplications and identify several putative target genes within the commonly gained region[J]. Leukemia, 2007, 21(10): 2137-2144.
[2]
Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia[J]. Nature, 2007, 446(7137): 758-764.
[3]
Borst L, Wesolowska A, Joshi T, et al. Genome-wide analysis of cytogenetic aberrations in ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia[J]. Br J Haematol, 2012, 157(4): 476-482.
[4]
Strefford JC, Worley H, Barber K, et al. Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization[J]. Oncogene, 2007, 26(29): 4306-4318.
[5]
Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification[J]. Nucleic Acids Res, 2002, 30(12): e57.
[6]
Schwab CJ, Chilton L, Morrison H, et al. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features[J]. Haematologica, 2013, 98(7): 1081-1088.
Schwab CJ, Jones LR, Morrison H, et al. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia[J]. Genes Chromosomes Cancer, 2010, 49(12): 1104-1113.
Nowak D, Liem NL, Mossner M, et al. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance[J]. Exp Hematol, 2015, 43(1): 32-43.
[11]
Loh ML, Mullighan CG. Advances in the genetics of highrisk childhood B-progenitor acute lymphoblastic leukemia and juvenile myelomonocytic leukemia: implications for therapy[J]. Clin Cancer Res, 2012, 18(10): 2754-2767.
[12]
Bokemeyer A, Eckert C, Meyr F, et al. Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia[J]. Haematologica, 2014, 99(4): 706-714.
[13]
Mrózek K, Harper DP, Aplan PD. Cytogenetics and molecular genetics of acute lymphoblastic leukemia[J]. Hematol Oncol Clin North Am, 2009, 23(5): 991-1010.
[14]
Othman MA, Melo JB, Carreira IM, et al. High rates of submicroscopic aberrations in karyotypically normal acute lymphoblastic leukemia[J]. Mol Cytogenet, 2015, 8: 45.
